Press Release – New York, NY – December 21, 2022 – Sichenzia Ross Ference LLP today announced that it represented Aegis Capital Corp. as sole book running manager in the $8 Million underwritten …
Sichenzia Ross Ference LLP Represents Laidlaw & Company (UK) Ltd. in $2.3 Million Registered Direct Offering of Common Stock and Concurrent Private Placement of Warrants of Amesite Inc.
Press Release – New York, NY – September 1, 2022 – Sichenzia Ross Ference LLP announced today that it represented Laidlaw & Company (UK) Ltd. as sole placement agent for Amesite Inc. (NASDAQ: …
Sichenzia Ross Ference LLP Represents Aegis Capital Corp. in $8 Million Simultaneous Registered Direct Offering and Private Placement of Securities of Kaspien Holdings Inc.
Press Release – New York, NY – July 14, 2022 – Sichenzia Ross Ference LLP announced today that it represented Aegis Capital Corp., acting as the exclusive placement agent, in a registered direct and …
Sichenzia Ross Ference LLP Represents Relmada Therapeutics, Inc. in $100 Million At-The-Market Offering Facility
Press Release – New York, NY – April 14, 2022 – Sichenzia Ross Ference LLP announced today that it represented Relmada Therapeutics, Inc. (NASDAQ: “RLMD”), a late-stage biotechnology company, in a …
Sichenzia Ross Ference LLP Represents Relmada Therapeutics, Inc. in $172.5 Million Upsized Public Offering Underwritten by Goldman Sachs and Jefferies
Press Release – New York, NY – December 14, 2021 – Sichenzia Ross Ference LLP today announced that it represented Relmada Therapeutics, Inc. (NASDAQ: RLMD), a late-stage biotechnology company …
Sichenzia Ross Ference LLP Represents Inmune Bio, Inc. in a $40.0 Million Registered Direct Offering
Press Release – New York, New York – July 16, 2021 - Sichenzia Ross Ference LLP announced today that it represented Inmune Bio, Inc. (Nasdaq: INMB), a clinical-stage immunology company focused on …
